CYP2A6 and cancer: As some important carcinogens such as aflatoxin B1 and nitosamines are metabolized by CYP2A6 (8), the lower activity of CYP2A6 in Iranian population poses them to a lower risk of cancer incidence due to active metabolites of these compounds.